D.E. Shaw & Co’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,316
| Closed | -$41K | – | 4256 |
|
|
2022
Q1 | $41K | Sell |
8,316
-10,375
| -56% | -$51.2K | ﹤0.01% | 3934 |
|
|
2021
Q4 | $128K | Buy |
+18,691
| New | +$128K | ﹤0.01% | 3604 |
|
|
2020
Q1 | – | Sell |
-8,263
| Closed | -$422K | – | 2737 |
|
|
2019
Q4 | $422K | Buy |
+8,263
| New | +$422K | ﹤0.01% | 2252 |
|
|
2019
Q3 | – | Sell |
-3,027
| Closed | -$167K | – | 2631 |
|
|
2019
Q2 | $167K | Sell |
3,027
-706
| -19% | -$39K | ﹤0.01% | 2438 |
|
|
2019
Q1 | $227K | Buy |
3,733
+386
| +12% | +$23.5K | ﹤0.01% | 2347 |
|
|
2018
Q4 | $198K | Buy |
3,347
+1,267
| +61% | +$75K | ﹤0.01% | 2386 |
|
|
2018
Q3 | $168K | Buy |
+2,080
| New | +$168K | ﹤0.01% | 2400 |
|
|
2016
Q2 | – | Sell |
-356
| Closed | -$67K | – | 2578 |
|
|
2016
Q1 | $67K | Sell |
356
-283
| -44% | -$53.3K | ﹤0.01% | 2510 |
|
|
2015
Q4 | $225K | Sell |
639
-305
| -32% | -$107K | ﹤0.01% | 2388 |
|
|
2015
Q3 | $495K | Sell |
944
-18
| -2% | -$9.44K | ﹤0.01% | 2037 |
|
|
2015
Q2 | $2.11M | Buy |
962
+27
| +3% | +$59.3K | ﹤0.01% | 1468 |
|
|
2015
Q1 | $2.19M | Hold |
935
| – | – | ﹤0.01% | 1324 |
|
|
2014
Q4 | $1.94M | Buy |
935
+84
| +10% | +$174K | ﹤0.01% | 1379 |
|
|
2014
Q3 | $1.7M | Buy |
851
+165
| +24% | +$329K | ﹤0.01% | 1303 |
|
|
2014
Q2 | $2.44M | Sell |
686
-45
| -6% | -$160K | ﹤0.01% | 1172 |
|
|
2014
Q1 | $2.73M | Buy |
731
+60
| +9% | +$224K | ﹤0.01% | 1113 |
|
|
2013
Q4 | $2.19M | Buy |
671
+24
| +4% | +$78.4K | ﹤0.01% | 1252 |
|
|
2013
Q3 | $2.71M | Buy |
647
+23
| +4% | +$96.2K | ﹤0.01% | 1128 |
|
|
2013
Q2 | $2.1M | Buy |
+624
| New | +$2.1M | ﹤0.01% | 1168 |
|